Ciclo celular/Ponto de verificação
Os inibidores do ciclo celular/ponto de verificação são compostos que interrompem a progressão normal do ciclo celular, particularmente em pontos de verificação regulatórios chave. Esses inibidores são cruciais para estudar a divisão celular, entender a proliferação de células cancerígenas e desenvolver terapias anticâncer. Ao direcionar fases específicas do ciclo celular, esses inibidores podem induzir a parada do ciclo celular, levando à apoptose ou senescência em células de divisão rápida. Na CymitQuimica, oferecemos uma ampla gama de inibidores de alta qualidade do ciclo celular/ponto de verificação para apoiar sua pesquisa em biologia do câncer, biologia celular e desenvolvimento de medicamentos.
Subcategorias de "Ciclo celular/Ponto de verificação"
- Aurora Quinase(94 produtos)
- CDK(500 produtos)
- Ciclo celular/Parada(4 produtos)
- Chk(42 produtos)
- DYRK(48 produtos)
- Dinamina(23 produtos)
- Ferroptose(215 produtos)
- HSP(169 produtos)
- Integrinas(224 produtos)
- Cinesina(66 produtos)
- LIM Quinase(19 produtos)
- Microtúbulo associado(261 produtos)
- PKC(102 produtos)
- PLK(28 produtos)
- ROCK(69 produtos)
- Rho(2 produtos)
- Wee1(15 produtos)
- c-Myc(69 produtos)
Exibir 10 mais subcategorias
Foram encontrados 3480 produtos de "Ciclo celular/Ponto de verificação"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
ROCK2-IN-5
<p>ROCK2-IN-5, a compound blending fasudil, caffeic, and ferulic acids, shows promise for ALS research involving SOD1 mutations.</p>Fórmula:C23H25N3O5SCor e Forma:SolidPeso molecular:455.53NSC666715
CAS:<p>NSC666715 is the strand-displacement activity of DNA polymerase inhibitor.</p>Fórmula:C15H13Cl2N5O2S2Pureza:98%Cor e Forma:SolidPeso molecular:430.33Cdc7-IN-17
CAS:<p>Cdc7-IN-17 is a potent inhibitor of CDC7 with an IC 50 of <10 μM that can be used in cancer research [1].</p>Fórmula:C13H15N5OSCor e Forma:SolidPeso molecular:289.36TCS 2314
CAS:<p>TCS 2314 is an orally active and selective very late antigen-4 antagonist (IC50: 4.4 nM).</p>Fórmula:C28H34N4O6Pureza:98%Cor e Forma:SolidPeso molecular:522.595,10-Dideazafolic acid
CAS:<p>5,10-Dideazafolic acid is an antileukemic drug.</p>Fórmula:C21H21N5O6Cor e Forma:SolidPeso molecular:439.42Sibrafiban
CAS:<p>Sibrafiban (RO 48-3657), an oral, nonpeptide prodrug, inhibits platelet aggregation as a selective IIb/IIIa antagonist.</p>Fórmula:C20H28N4O6Cor e Forma:SolidPeso molecular:420.46THZ1-R
CAS:<p>THZ1-R is a non-covalent active analogue of THZ1, with the acrylamide group removed from THZ1, not covalently bind to the C312 cysteine residue of CDK7.</p>Fórmula:C31H30ClN7O2Pureza:98%Cor e Forma:SolidPeso molecular:568.07MSC-1186
CAS:<p>MSC-1186 selectively inhibits SRPKs—IC50: 2.7nM (SRPK1), 81nM (SRPK2), 0.6nM (SRPK3)—for cancer research.</p>Fórmula:C19H17ClFN7O2SCor e Forma:SolidPeso molecular:461.9CDK8-IN-4
CAS:<p>CDK8-IN-4 is an inhibitor of CDK8 (IC50: 0.2 nM).</p>Fórmula:C20H18N4OCor e Forma:SolidPeso molecular:330.38DHODH-IN-12
CAS:<p>DHODH-IN-12 is a leflunomide derivative and a weak dihydrorotate dehydrogenase (DHODH) inhibitor with a pKa of 5.07.</p>Fórmula:C10H9N3O2Pureza:99.53%Cor e Forma:SolidPeso molecular:203.2Carbonic anhydrase inhibitor 14
CAS:<p>CA inhibitor 14 blocks hCA I/II/IX/XII (K i of 1203/99.7/9.4/27.7 nM) and CDK2 (IC50: 20.3 μM), showing antitumor effects.</p>Fórmula:C18H17N7O2SCor e Forma:SolidPeso molecular:395.448RK64
CAS:<p>8RK64 is a covalent UCHL1 inhibitor ( IC 50 : 0.32 μM) .</p>Fórmula:C14H16N8O2SCor e Forma:SolidPeso molecular:360.4CGP 53353
CAS:<p>CGP 53353 (DAPH-7) is a PKC inhibitor with inhibitory effects on PKCβII and PKCβI and can be used to study atherosclerosis.</p>Fórmula:C20H13F2N3O2Pureza:98.11%Cor e Forma:SolidPeso molecular:365.33DHODH-IN-20
CAS:<p>Dhodh-in-20 (Compound 133), a potent DHODH inhibitor, may help study acute myeloid leukemia and inhibit tumor growth.</p>Fórmula:C24H25F4N3O3Cor e Forma:SolidPeso molecular:479.47Bis-Pro-5FU
CAS:<p>Bis-Pro-5FU enhances oral uptake and safety of 5-FU, an anti-cancer drug for colorectal and pancreatic tumors.</p>Fórmula:C10H7FN2O2Cor e Forma:SolidPeso molecular:206.17CFI-400437
CAS:<p>CFI-400437 is an ATP-competitive PLK4 inhibitor (IC50: 0.6 nM) and is an indolequinone derivative.</p>Fórmula:C29H28N6O2Cor e Forma:SolidPeso molecular:492.57HBX28258
CAS:<p>HBX28258, a human USP7 inhibitor, binds covalently and selectively deactivates USP7 in colon cancer and kidney cells.</p>Fórmula:C26H30ClN3OPureza:98%Cor e Forma:SolidPeso molecular:435.99SR7826
CAS:<p>SR7826 is a selective LIMK inhibitor.</p>Fórmula:C22H21N5O2Pureza:98%Cor e Forma:SolidPeso molecular:387.43XMD-17-51
CAS:<p>XMD-17-51 has DCLK1 kinase inhibitory activity, inhibits DCLK1 and cell proliferation, and can be used in lung cancer research.</p>Fórmula:C21H24N8OPureza:99.04%Cor e Forma:SoildPeso molecular:404.47ML366
CAS:<p>ML366 is a Vibrio cholerae Quorum Sensing inhibitor Acting via the LuxO response regulator.</p>Fórmula:C17H19N3O4Pureza:98%Cor e Forma:SolidPeso molecular:329.35Fozivudine tidoxil
CAS:<p>Fozivudine tidoxil, a reverse transcriptase inhibitor, is used potentially for the treatment of HIV infection.</p>Fórmula:C35H64N5O8PSCor e Forma:SolidPeso molecular:745.95Valategrast
CAS:<p>Valategrast: potent, oral dual α4β1/α4β7 integrin antagonist, may treat COPD and asthma.</p>Fórmula:C30H32Cl3N3O4Pureza:98%Cor e Forma:SolidPeso molecular:604.95JFN05510
CAS:<p>Compound: 3'-O-tert-BDMS-5'-O-DMT-N2-IBG 2'-CE phosphoramidite; has anticancer properties and activates enzymes.</p>Fórmula:C50H68N7O9PSiCor e Forma:SolidPeso molecular:970.18Aditoprime
CAS:<p>Aditoprime inhibits bacterial growth by blocking DHFR, effective against L.casei and E.coli with IC50 of 520/47 nM.</p>Fórmula:C15H21N5O2Cor e Forma:SolidPeso molecular:303.36Cdc7-IN-4
CAS:<p>Cdc7-IN-4 is a potent inhibitor of Cdc7 kinase.</p>Fórmula:C22H24F3N5O4Pureza:98%Cor e Forma:SolidPeso molecular:479.452-Keto-D-galactose
CAS:<p>2-Keto-D-galactose inhibits DNA synthesis and inhibits the proliferation of in vitro grown Ehrlich ascites tumor cells.</p>Fórmula:C6H10O6Pureza:98%Cor e Forma:SolidPeso molecular:178.14PKC-9
CAS:<p>PKC-9 is a PKC-zeta inhibitor 9.</p>Fórmula:C25H25N7Cor e Forma:SolidPeso molecular:423.51AM-TS23
CAS:<p>AM-TS23 is used as a DNA polymerase lambda and beta inhibitor.</p>Fórmula:C17H12N2O3S3Pureza:98%Cor e Forma:SolidPeso molecular:388.48CAP-53194
CAS:<p>CAP-53194 is a selective Plk1 inhibitor.</p>Fórmula:C21H14N6O5Pureza:98%Cor e Forma:SolidPeso molecular:430.37CDK7-IN-15
CAS:<p>CDK7-IN-15, a pyrimidine-based potent CDK7 inhibitor, shows promise for various cancers with defective transcription.</p>Fórmula:C21H24F4N6OSCor e Forma:SolidPeso molecular:484.51GSK-3008348
CAS:<p>GSK-3008348 is an antagonist of integrin alpha(v)beta6.</p>Fórmula:C29H37N5O2Pureza:99.547%Cor e Forma:SolidPeso molecular:487.64IACS-4759
CAS:<p>IACS-4759 is a novel potent and selective MTH1 inhibitor with excellent cell permeability and good metabolic stability in microsomes.</p>Fórmula:C10H17N3O2Cor e Forma:SolidPeso molecular:211.26LDN-209929 dihydrochloride
CAS:<p>LDN-209929 dihydrochloride: potent haspin kinase inhibitor, 55 nM IC50, 180x more selective than DYRK2.</p>Fórmula:C17H19Cl3N2OSCor e Forma:SolidPeso molecular:405.77Cylindrospermopsin
CAS:<p>Cylindrospermopsin: a toxic cyanobacterial uracil derivative, disrupts protein/glutathione synthesis in hepatocytes, and is genotoxic.</p>Fórmula:C15H21N5O7SCor e Forma:SolidPeso molecular:415.42Mivobulin Isethionate
CAS:<p>Mivobulin, a tubulin inhibitor (CI-980), may treat glioma, melanoma, prostate, and ovarian cancer, targeting colchicine-binding site.</p>Fórmula:C19H25N5O6SPureza:98%Cor e Forma:SolidPeso molecular:451.5BAY-707
CAS:<p>BAY-707: tolerable in mice, no anticancer efficacy; potent, selective MTH1 inhibitor, IC50 = 2.3 nM; good PK profile.</p>Fórmula:C15H20N4O2Pureza:98%Cor e Forma:SolidPeso molecular:288.34Picoplatin
CAS:<p>Picoplatin, an anti-cancer agent overcoming platinum resistance, alkylates DNA to block replication, transcription, and induce apoptosis.</p>Fórmula:C6H10Cl2N2PtPureza:98%Cor e Forma:SolidPeso molecular:376.14HHL-6
CAS:<p>HHL-6 is a c-Fos and BDNF protein expression modulator.</p>Fórmula:C19H26N2O3Cor e Forma:SolidPeso molecular:330.42MDK6204
CAS:<p>MDK6204 is a selective inhibitor of CLK1 and CLK2.</p>Fórmula:C20H20N6OPureza:98%Cor e Forma:SolidPeso molecular:360.41Metralindole HCl
CAS:<p>Metralindole is a reversible monoamine oxidase A (RIMA) inhibitor, it was investigated as a potential antidepressant.</p>Fórmula:C15H18ClN3OPureza:98%Cor e Forma:SolidPeso molecular:291.78Fosteabine
CAS:<p>Fosteabine is an oral and prodrug analog of cytarabine. It is resistant to deoxycytidine deaminase.</p>Fórmula:C27H50N3O8PPureza:98%Cor e Forma:SolidPeso molecular:575.67HR22C16
CAS:<p>HR22C16 is an effective, selective, and cell-permeable mitotic kinesin Eg5 inhibitor.</p>Fórmula:C23H23N3O3Cor e Forma:SolidPeso molecular:389.45Zalunfiban
CAS:<p>RUC-4 is an aIIb 3 antagonist. It is also used for prehospital therapy of myocardial infarction.</p>Fórmula:C16H18N8O2SCor e Forma:SolidPeso molecular:386.43HIPP
CAS:<p>HIPP is a highly selective inhibitor of antineoplastic CtBP.</p>Fórmula:C9H9NO3Cor e Forma:SolidPeso molecular:179.17NPD9948
CAS:<p>NPD9948 is a competitive inhibitor of MTH1.</p>Fórmula:C13H14N6Cor e Forma:SolidPeso molecular:254.29LDN-209929
CAS:<p>LDN-209929 2HCl is a potent and selective inhibitor of haspin kinase.</p>Fórmula:C17H17ClN2OSCor e Forma:SolidPeso molecular:332.85DYRKi
CAS:<p>DYRKi is a nontoxic, DYRK1-selective inhibitor.</p>Fórmula:C20H13F3N4O2SCor e Forma:SolidPeso molecular:430.4BIPM
CAS:<p>BIPM inhibits ROCK2, alters SH-SY5Y cell migration, actin fibers, neurite length, and reduces cofilin phosphorylation.</p>Fórmula:C23H22N2O3Cor e Forma:SolidPeso molecular:374.43Cdc7-IN-14
CAS:<p>Cdc7-IN-14 (compound 82) is a potent CDC7 inhibitor with an IC50 < 1 nM, promising for cancer research.</p>Fórmula:C18H20N4O2SCor e Forma:SolidPeso molecular:356.44JTK-101
CAS:<p>JTK-101 is a potent and selective Tat-dependent HIV-1 replication inhibitor.</p>Fórmula:C25H23N3O3Cor e Forma:SolidPeso molecular:413.47D-Xylofuranose, 1,2,3,5-tetraacetate
CAS:<p>1,2,3,5-Tetra-O-acetyl-D-xylofuranose is a starting material for the synthesis of nucleosides.</p>Fórmula:C13H18O9Cor e Forma:SolidPeso molecular:318.28Rho-Kinase-IN-2
CAS:<p>Rho-Kinase-IN-2, an oral ROCK inhibitor (IC50=3nM), penetrates the CNS; potential in Huntington's research.</p>Fórmula:C20H25FN4O2Cor e Forma:SolidPeso molecular:372.44REV7/REV3L-IN-1
CAS:<p>REV7/REV3L-IN-1 is a inhibitor of REV7/REV3L interaction(IC50 of 78 μM),</p>Fórmula:C19H21N3O3SPureza:98%Cor e Forma:SolidPeso molecular:371.45NSC47924
CAS:<p>NSC47924 is a laminin receptor (LR) inhibitor.</p>Fórmula:C18H17NO2Pureza:98%Cor e Forma:SolidPeso molecular:279.33L-Guanosine
CAS:<p>L-Guanosine is the L-configuration of Guanosine. Guanosine is a purine nucleoside that has anti-herpesvirus activity [1] [2].</p>Fórmula:C10H13N5O5Cor e Forma:SolidPeso molecular:283.24AB-182
CAS:<p>AB-182 is an aziridine derivative with antitumor activity.</p>Fórmula:C11H22N3O4PCor e Forma:SolidPeso molecular:291.28Guanoctine hydrochloride
CAS:<p>Guanoctine hydrochloride has antihypertensive activity.</p>Fórmula:C9H22ClN3Cor e Forma:SolidPeso molecular:207.74Homocarbonyltopsentin
CAS:<p>Homocarbonyltopsentin: Small molecule, binds TSL2 pentaloops, enhances SMN2 E7 splicing, EC50 16 μM.</p>Fórmula:C21H14N4O3Pureza:98%Cor e Forma:SolidPeso molecular:370.36Ro 43-5054
CAS:<p>Ro 43-5054 is a small molecular, noncyclic peptidomimetic inhibitor.</p>Fórmula:C24H27N5O7Pureza:98%Cor e Forma:SolidPeso molecular:497.5Myt1-IN-1
CAS:<p>Myt1-IN-1 has anticancer effects that is a potent inhibitor of Myt1 with an IC 50 of <10 nM [1].</p>Fórmula:C16H15ClN4O2Cor e Forma:SolidPeso molecular:330.77ROCK-IN-D1
CAS:<p>ROCK-IN-D1 is an effective and selective inhibitor of ROCK.</p>Fórmula:C22H27N5O2SPureza:98%Cor e Forma:SolidPeso molecular:425.55DHODH-IN-15
CAS:<p>DHODH-IN-15, a hydroxyfuran analogue of A771726, inhibits rat liver DHODH with an IC50 of 11 μM, and is used for rheumatoid arthritis.</p>Fórmula:C15H11N3O3Pureza:99.8%Cor e Forma:SolidPeso molecular:281.27SNX2-1-108
CAS:<p>SNX2-1-108 is a selective CDK8 and CDK19 inhibitor.</p>Fórmula:C21H16N4Pureza:98%Cor e Forma:SolidPeso molecular:324.38UIAA-II-232
CAS:<p>UIAA-II-232 (compound 19b) is a potent inhibitor of DNA gyrase catalytic (IC 50= 3.5 μM).</p>Fórmula:C20H24FN5O3Cor e Forma:SolidPeso molecular:401.43Protein kinase D inhibitor 1
CAS:<p>Protein kinase D inhibitor 1 (17m) is a potent pan-PKD suppressant with IC50 of 17-35 nM, targeting cortactin phosphorylation.</p>Fórmula:C19H21N7Cor e Forma:SolidPeso molecular:347.42RUC-1
CAS:<p>RUC-1 is an αIIbβ3-selective ADP-induced platelet aggregation inhibitor.</p>Fórmula:C11H15N5OSPureza:98%Cor e Forma:SolidPeso molecular:265.33LIMK-IN-14
CAS:<p>LIMK-IN-14 is an effective and selective inhibitor of LIMK.</p>Fórmula:C22H27N7O3Pureza:98%Cor e Forma:SolidPeso molecular:437.49Denopterin
CAS:<p>Denopterin is an antineoplastic agent.</p>Fórmula:C21H23N7O6Pureza:98%Cor e Forma:SolidPeso molecular:469.45FINDY
CAS:<p>FINDY selectively inhibits DYRK1A at 35 μM IC50, blocking Ser97 autophosphorylation, useful for neurological disorder research.</p>Fórmula:C16H17NO2S2SiCor e Forma:SolidPeso molecular:347.53PV-1019
CAS:<p>PV-1019 (NSC 744039), a potent Chk2 inhibitor, has an IC50 of 24 nM and blocks Chk2 autophosphorylation and IR-induced apoptosis.</p>Fórmula:C18H17N7O3Cor e Forma:SolidPeso molecular:379.37Scaff10-8
CAS:<p>Scaff10-8 blocks AKAP-Lbc-RhoA, aiding aquaporin-2 movement in kidney cells.</p>Fórmula:C22H18O6Pureza:98%Cor e Forma:SolidPeso molecular:378.37Antibacterial agent 124
CAS:<p>Antibacterial agent 124 inhibits Sa ProRS with an IC50 of 0.18 μM.</p>Fórmula:C16H17ClFN3O2Cor e Forma:SolidPeso molecular:337.78RK-9123016
CAS:<p>RK-9123016 is a SIRT2 inhibitor.</p>Fórmula:C16H18N6O3SPureza:99.65%Cor e Forma:SolidPeso molecular:374.42Aurora kinase inhibitor-9
CAS:<p>Aurora kinase inhibitor-9 (9d) targets AURKA/B with IC50: 0.093 μM for A and 0.09 μM for B, with wide anti-proliferative effects.</p>Fórmula:C19H17Cl2N3O4SCor e Forma:SolidPeso molecular:454.33Aurora Kinases-IN-2
CAS:<p>Aurora Kinases-IN-2 (12Aj) hinders Aurora A/B kinases (IC50: 90/152 nM), used in cancer studies.</p>Fórmula:C22H18ClN5O3Cor e Forma:SolidPeso molecular:435.861-Acetyl-3-o-toluyl-5-fluorouracil
CAS:<p>1-Acetyl-3-o-toluyl-5-fluorouracil is a potent antineoplastic agent.</p>Fórmula:C14H11FN2O4Pureza:98%Cor e Forma:SolidPeso molecular:290.25Rabacfosadine succinate
CAS:<p>Rabacfosadine succinate is the acyclic nucleoside phosphonate PMEG double prodrug.</p>Fórmula:C25H41N8O10PPureza:98%Cor e Forma:SolidPeso molecular:644.623Thiamiprine
CAS:<p>Thiamiprine is an agent with the activity of antineoplastic.</p>Fórmula:C9H8N8O2SCor e Forma:SolidPeso molecular:292.28MK-0668
CAS:<p>MK-0668 is a very potent and orally active very late antigen-4 antagonist.</p>Fórmula:C31H30Cl2N6O6SCor e Forma:SolidPeso molecular:685.58BI-831266
CAS:<p>BI-831266 is a potent and selective Aurora kinase B inhibitor.</p>Fórmula:C27H38ClN7O2Cor e Forma:SolidPeso molecular:528.09CDK-IN-10
CAS:<p>CDK-IN-10 is a cell cycle protein-dependent kinase (CDK) inhibitor with potential anticancer activity for cancer research.</p>Fórmula:C18H18N4O2Pureza:97.07%Cor e Forma:SolidPeso molecular:322.36LSN 3213128
CAS:<p>LSN 3213128: a potent oral antifolate targeting AICARFT with IC50s of 16 nM (enzyme) and 19 nM (cells), offers anti-tumor effects.</p>Fórmula:C17H16FN3O4S2Cor e Forma:SolidPeso molecular:409.45Indirubin-3'-monoxime-5-sulphonic acid
CAS:<p>Indirubin-3'-monoxime-5-sulphonic acid is a potent and selective inhibitor of GSK-3β, CDK5, and CDK1 with IC50s of 80nM,5 nM, and 7 nM, respectively.</p>Fórmula:C16H11N3O5SPureza:98%Cor e Forma:SolidPeso molecular:357.34LIMK1 inhibitor BMS-4
CAS:<p>BMS-4 is a LIMK inhibitor targeting LIMK1/2, reduces cofilin phosphorylation, noncytotoxic to A549 cells.</p>Fórmula:C23H23N7O2SCor e Forma:SolidPeso molecular:461.54RSK-IN-1
CAS:<p>RSK-IN-1 (compound 7d) shows anti-tumor activity. RSK-IN-1 is an inhibitor of RSK that inhibits the phosphorylation of YB-1 [1].</p>Fórmula:C22H17NO2Cor e Forma:SolidPeso molecular:327.38LY 222306
CAS:<p>LY 222306 is a glycinamide ribonucleotide formyltransferase (GARFT) inhibitor with a Ki of 0.77 nM.</p>Fórmula:C19H23N5O7Pureza:98%Cor e Forma:SolidPeso molecular:433.42Type II topoisomerase inhibitor 1
CAS:<p>Potent E. coli DNA gyrase inhibitor (IC50: 1.7 nM), targets Asp73; weak topoisomerase IV inhibitor (IC50: 0.98 μM).</p>Fórmula:C18H15N3O4Cor e Forma:SolidPeso molecular:337.33Dihydro-5-azacytidine acetate
CAS:<p>Dihydro-5-azacytidine acetate (DHAC), a nucleoside analog, becomes integrated into DNA, thereby inhibiting DNA methylation, and exhibits antitumor activity [1</p>Fórmula:C10H18N4O7Pureza:98%Cor e Forma:SolidPeso molecular:306.27MLAF50
CAS:<p>MLAF50 is an inhibitor of the REV1 UBM2-Ubiquitin interaction.</p>Fórmula:C15H12I2O4Cor e Forma:SolidPeso molecular:510.06IRE1α kinase-IN-8
CAS:<p>IRE1α kinase-IN-8, a benzoheterocyclecarboxaldehyde derivative, serves as a potent inhibitor of IRE-1α.</p>Fórmula:C23H22N2O5Pureza:98%Cor e Forma:SolidPeso molecular:406.43DDD100097
CAS:<p>DDD100097 is a N-myristoyltransferase inhibitor with potential inhibitory effects on Trypanosoma brucei, which can be used to study neurological disorders.</p>Fórmula:C22H30Cl2F2N4O2SPureza:98.89%Cor e Forma:SolidPeso molecular:523.47Thiarabine
CAS:<p>Thiarabine displays effective anti-tumor activity. It also inhibition of DNA synthesis.</p>Fórmula:C9H13N3O4SPureza:98%Cor e Forma:SolidPeso molecular:259.28FUBP1-IN-2
CAS:<p>FUBP1-IN-2 hinders FUBP1, affects c-Myc and p21 expression, and depletes polyamines.</p>Fórmula:C26H26ClN3O4Cor e Forma:SolidPeso molecular:479.96Ipivivint
CAS:<p>Ipivivint: orally active, potent CLK inhibitor; hinders CLK1, CLK2, & CLK3; curbs Wnt signaling & SRSF phosphorylation for cancer research.</p>Fórmula:C26H21FN8Cor e Forma:SolidPeso molecular:464.5USP28-IN-2
CAS:<p>USP28-IN-2 selectively inhibits USP28 (IC50=0.3 μM), degrades c-Myc, kills cancer cells, lowers ankyrin-1/2, and enhances Regorafenib effects.</p>Fórmula:C23H20Cl2N2O3SCor e Forma:SolidPeso molecular:475.39ROCK-IN-4
CAS:<p>ROCK-IN-4: Inhibits ROCK, sustains NO release, disrupts F-actin, hinders HTM cell respiration, aids glaucoma research.</p>Fórmula:C20H26ClFN4O7SCor e Forma:SolidPeso molecular:520.96PD-1-IN-22
CAS:<p>PD-1-IN-22 is a potent programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) interaction inhibitor(IC50 of 92.3 nM).</p>Fórmula:C25H25N5O4Pureza:99.51%Cor e Forma:SolidPeso molecular:459.5DHODH-IN-8
CAS:<p>DHODH-IN-8 is a DHODH inhibitor with antimalarial properties, IC50: 0.13 μM (human), 47.4 μM (P. falciparum); Ki: 0.016 μM (human), 5.6 μM (P. falciparum).</p>Fórmula:C17H13ClN2O2Pureza:99.78%Cor e Forma:SolidPeso molecular:312.75AS-136A
CAS:<p>AS-136A is an orally active MV RdRp inhibitor with antiviral activity that inhibits measles virus and blocks viral RNA synthesis.</p>Fórmula:C17H19F3N4O3SPureza:98.52%Cor e Forma:SolidPeso molecular:416.42Cdc7-IN-15
CAS:<p>Cdc7-IN-15 (Example 108) is an inhibitor of cdc7 kinase that has potential to be used for cancer research [1].</p>Fórmula:C12H14N4OSCor e Forma:SolidPeso molecular:262.33
